Moderna dominates Wall St trading ahead of S&P 500 debut
Moderna dominates Wall St trading ahead of S&P 500 debut
Moderna’s stock dropped 2% in a volatile session on Tuesday, with the COVID-19 vaccine maker the most heavily traded company on Wall Street ahead of its debut in the S&P 500 on Wednesday. Read More